Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Fosun Pharmaceutical Gets FDA Green Light for HLX42 ADC Clinical Study

April 2, 2025
CompanyDeals

Simcere Pharmaceutical Secures Rights to Develop Rademikibart in China

November 4, 2024
Company

Bayer Invests USD 130 Million in Parenteral Drugs Manufacturing Site in Germany

November 4, 2024
Company

Novo Nordisk Invests DKK 16 Billion to Expand French Production Facility

November 4, 2024
CompanyDeals

Shanghai Escugen Partners with Foreseen Biotechnology for ADC Development

December 3, 2024
Policy / Regulatory

European Commission Proposes Overhaul of Pharmaceutical Legislation

November 4, 2024
CompanyDrug

Pyrotech Biotechnology’s PTT-936 Gets US FDA Clinical Trial Approval

November 4, 2024
CompanyDrug

Boehringer Ingelheim and Eli Lilly’s Jardiance Receives NMPA Approval for CKD Treatment

November 4, 2024
CompanyDeals

Zhejiang Huanqing Medical Technology Secures Series A Financing for Heart Failure Innovations

November 4, 2024
CompanyDrug

Boehringer Ingelheim and Eli Lilly Secure NMPA Approval for Jardiance in Chronic Kidney Disease

November 4, 2024
CompanyDeals

True Health Secures Over RMB 100 Million in Series B+ Financing for Surgical Robot Development

November 4, 2024
CompanyDrug

MicuRx Pharmaceuticals Secures NMPA Approval for MRX-4 and Contezolid Combination Therapy

November 4, 2024
1 2 … 4 5 6 7 8 … 25 26
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up